Market Place
Sourcing Support
Milla and Alter Announce Yet Another “First Cycle” FDA Approval for Dexmedetomidine Hydrochloride Injection
09 Jun 2023 //
BUSINESSWIRE
Milla and the Alter Announce Launch of a Generic Version of Magnesium Sulfate
20 Mar 2023 //
BUSINESSWIRE
Milla and Alter Group Announce First Paragraph IV Filing and Acceptance by FDA
26 Oct 2022 //
BUSINESSWIRE
Third ANDA Approval for Milla Pharma and 4th U.S. Approval for Alter Pharma
19 Apr 2022 //
BUSINESSWIRE
Alter Pharma Acquires EcoPharmaSupply
06 Apr 2022 //
BUSINESSWIRE
Milla Pharmaceuticals Announces Approval of Sodium Acetate Injection
26 Aug 2021 //
BUSINESSWIRE
Hyloris Successfully Renegotiates License Agreements with the Alter Pharma Group
24 Jun 2021 //
GLOBENEWSWIRE
Luye Pharma Signs Two Agreements in Latin America, Global Business System
11 Sep 2020 //
PRNNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.